companydata.dkBIODANE PHARMA A/S: Financial statements 2014
CVR: 28310102
BIODANE PHARMA A/S (CVR 28310102) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 278,919 and a net result of DKK -250,379 compared with DKK -976,558 the year before. That is an increase of 162.5% compared with the year before. Equity amounted to DKK 986,576. The solvency ratio was 89.5%.
- Gross Profit
- 278,919 kr.
- Profit/Loss
- -250,379 kr.
- Equity
- 986,576 kr.
- Total Assets
- 1,102,873 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | 279 t. | -250 t. | 987 t. | - |
| 2013 | - | 106 t. | -977 t. | -263 t. | - |
| 2012 | - | 384 t. | 8 t. | 714 t. | - |
Keep an eye on BIODANE PHARMA A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2014
BIODANE PHARMA A/S has published its annual report for 2013. Gross profit came to DKK 106,251, and the net result was DKK -976,558.
About BIODANE PHARMA A/S
BIODANE PHARMA A/S is a Danish company of the type Aktieselskab based in Gesten, founded in 2004. The company is registered under the industry Fremstilling af andre fødevarer i.a.n.. The management consists of Gunner Kreutzer Jakobsen. The company is owned by BIODAN A/S. In 2025, the company reported a gross profit of DKK 2,534,166 and a net result of DKK 182,862 compared with DKK 1,651,356 the year before. Equity amounted to DKK 2,505,002.